Analyze Diet

Topic:Immune Response

The immune response in horses involves a complex network of cells, tissues, and molecules that work together to protect the animal from pathogens and other harmful agents. This process includes both innate and adaptive immune mechanisms. Innate immunity provides the first line of defense and involves components such as physical barriers, phagocytic cells, and the complement system. Adaptive immunity, on the other hand, is characterized by the activation of lymphocytes and the production of antibodies, which provide a targeted response to specific antigens. Key components of the equine immune system include T cells, B cells, and various cytokines that facilitate communication between immune cells. This page compiles peer-reviewed research studies and scholarly articles that explore the mechanisms, regulation, and implications of immune responses in equine health.
Resistance of horses infected chronically with equine infectious anemia virus against reinfection.
National Institute of Animal Health quarterly    January 1, 1973   Volume 13, Issue 4 173-181 
Kono Y, Fukunaga Y, Kobayashi K.No abstract available
Effect of back passage of Venezuelan equine encephalomyelitis TC-83 vaccine virus on clinical, virologic, and immune responses in horses.
Journal of the American Veterinary Medical Association    October 1, 1972   Volume 161, Issue 7 824-831 
Luedke AJ, Barber TL, Foster NM, Batalla D, Mercado S.No abstract available
[Mechanisms of action of interferon].
Antibiotiki    October 1, 1972   Volume 17, Issue 10 940-945 
Tazulakhova EB, Ershov FI.No abstract available
Equine anaphylaxis.
Journal of the American Veterinary Medical Association    September 1, 1972   Volume 161, Issue 5 438 
Mansmann RA.No abstract available
[Sensitization studies using dexamethasone and carboxymethylcellulose in the horse].
Schweizer Archiv fur Tierheilkunde    September 1, 1972   Volume 114, Issue 9 439-449 
Straub R, Lazary S, Gerber H, De Weck AL, Schatzmann U, Pauli B.No abstract available
Central nervous system response of horses to Venezuelan equine encephalomyelitis vaccine (TC-83).
Journal of the American Veterinary Medical Association    August 1, 1972   Volume 161, Issue 3 265-269 
Monlux WS, Luedke AJ, Bowne J.No abstract available
A study of different equine influenza vaccination schedules in seronegative foals and in horses.
Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B    July 1, 1972   Volume 20, Issue 5 361-366 doi: 10.1111/j.1439-0450.1973.tb01137.x
Petermann HG, Stellmann C, Graveline P.No abstract available
Pathologic changes in experimental equine anaphylaxis.
Journal of the American Veterinary Medical Association    June 15, 1972   Volume 160, Issue 12 1632-1636 
McGavin MD, Gronwall RR, Mia AS.No abstract available
Inhibition of the mixed lymphocyte reaction by antibodies.
Transplantation proceedings    June 1, 1972   Volume 4, Issue 2 173-176 
Revillard JP, Robert M, Betuel H, Latour M, Bonneau M, Brochier J, Traeger J.No abstract available
[Serological studies following immunization against horse influenza. 3. Reimmunization two years following first vaccination and antibody level during an interval of three years]. Pressler K.No abstract available
Experimental infection of horses with an attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83).
Infection and immunity    May 1, 1972   Volume 5, Issue 5 750-756 doi: 10.1128/iai.5.5.750-756.1972
Walton TE, Alvarez O, Buckwalter RM, Johnson KM.Ten horses (Equus caballus) were vaccinated with strain TC-83 Venezuelan equine encephalomyelitis (VEE) virus vaccine. Febrile responses and leukopenia due to a reduction of lymphocytes and neutrophils were observed in all animals. Viremias were demonstrable in eight horses, with a maximum of 10(3.5) median tissue culture infectious dose units per ml of serum in two horses. Clinical illness with depression and anorexia were observed in five horses. Neutralizing (N), hemagglutination-inhibiting, and complement-fixing antibodies to the vaccine virus were demonstrable by 5, 6.5, and 7 days, respe...
Field studies of an attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83).
Infection and immunity    February 1, 1972   Volume 5, Issue 2 160-163 doi: 10.1128/iai.5.2.160-163.1972
Eddy GA, Martin DH, Reeves WC, Johnson KM.A series of field studies using strain TC-83 attenuated Venezuelan equine encephalomyelitis vaccine in horses was made to determine the rate of seroconversions, the postvaccination viremia, and the possibility of adverse reactions to the vaccine. The rate of seroconversions varied from 50% in one study to 91 and 100% in two others. The highest level of viremia measured was 7 x 10(3) to 8 x 10(3) plaqueforming units per ml. No adverse reactions to the vaccine were observed in any horses, including 42 pregnant mares and their resulting foals.
Leucocyte migration inhibition in horses immunized with detoxified scorpion venom.
Archives de l'Institut Pasteur d'Algerie. Institut Pasteur d'Algerie    January 1, 1972   Volume 50-51 121-129 
Brahmi Z.No abstract available
An in vitro immune response to penicillin.
Journal of immunology (Baltimore, Md. : 1950)    July 1, 1971   Volume 107, Issue 1 302-305 
Naor D, Henry C, Fudenberg HH.No abstract available
Immunogenicity of purified venezuelan equine encephalitis virus inactivated by ionizing radiation.
Infection and immunity    April 1, 1971   Volume 3, Issue 4 574-579 doi: 10.1128/iai.3.4.574-579.1971
Gruber J.Purified and concentrated Venezuelan equine encephalitis (VEE) virus derived from tissue cultures, rendered noninfectious by ionizing radiation with retention of in vitro serological activity, also retained a high level of immunogenicity. In mice, fluid vaccines afforded excellent protection against lethal challenge with homologous Trinidad strain VEE virus. A direct relationship was observed between concentration of vaccine or number of injections and survival. One intraperitoneal inoculation of undiluted vaccine protected essentially all mice challenged 21 days later with 100,000 mouse intra...
The intravenous administration of equine antilymphocytic globulin in renal transplant recipients and the detection of circulating antibodies to equine globulin.
Clinical and experimental immunology    April 1, 1971   Volume 8, Issue 4 529-542 
James K, Pullar DM, Morton JB, Dalton RG, Nolan B, Woodruff MF.Methods are described for the intravenous administration of equine antilymphocytic globulin (ALG) to renal transplant recipients. The development of circulating antibodies to the equine IgG has been investigated using primary and secondary immunological procedures. The need for primary immunoassay procedures to assess both the immune response and induction of tolerance to equine IgG in ALG treated patients is extensively discussed.
Immunosuppression by antihuman lymphocyte globulin: correlation of human and animal assay systems with clinical results.
Transplantation proceedings    March 1, 1971   Volume 3, Issue 1 745-748 
Simmons RL, Moberg AW, Gewurz H, Soll R, Najarian JS.No abstract available
Increasing effectiveness of antilymphocytic globulin by prevention of antibody formation to horse IgG.
Transplantation proceedings    March 1, 1971   Volume 3, Issue 1 733-736 
Butler WT, Rossen RD.No abstract available
Evaluation of enterovirus immune horse serum pools for identification of virus field strains.
Bulletin of the World Health Organization    January 1, 1971   Volume 45, Issue 3 317-330 
Schmidt NJ, Melnick JL, Wenner HA, Ho HH, Burkhardt MA.Immune horse sera to 42 enterovirus immunotypes were pooled according to the Lim Benyesh-Melnick and the "intersecting serum" schemes. Each serum was diluted in the pools to contain 50 antibody units. After it was established that the pools correctly neutralized prototype virus strains, they were evaluated in tests against 273 enterovirus field strains representing most of the viral types included in the pools. With test virus doses of 10-100 TCD(50), most of the poliovirus and coxsackievirus field strains were correctly identified in both schemes, but a number of the echoviruses were neutrali...
The effect of a corticosteroid combination on blood and synovial fluid in horses.
Veterinary medicine, small animal clinician : VM, SAC    October 1, 1970   Volume 65, Issue 10 963-966 
Houdeshell JW.No abstract available
Pretreatment with deaggregated horse gamma-globulin. Failure to enhance tolerance to horse antilymphoblast globulin in man.
Transplantation    October 1, 1970   Volume 10, Issue 4 344-346 
Moberg AW, Gewurz H, Simmons RL, Najarian JS.No abstract available
The plasmapheresis of hyperimmunized horses.
Bulletin of the World Health Organization    January 1, 1970   Volume 42, Issue 6 998-1000 
Levine L, Broderick EJ.No abstract available
Cellular response to equine encephalomyelitis vaccine in skin window of horses.
American journal of veterinary research    January 1, 1970   Volume 31, Issue 1 97-102 
Zarrilli LW, Calhoun ML.No abstract available
Immunization of horses against equine infectious anemia (EIA) with an attenuated EIA virus.
National Institute of Animal Health quarterly    January 1, 1970   Volume 10, Issue 3 113-122 
Kono Y, Kobayashi K, Fukunaga Y.No abstract available
Nature of complement-fixing antibodies in horses infected with equine rhinopneumonitis virus.
National Institute of Animal Health quarterly    January 1, 1970   Volume 10, Issue 3 123-128 
Suzuki T, Nakano K, Shimizu Y, Isayama Y, Kawakami Y.No abstract available
Reactivities to horse anti-lymphocyte globulin. I. Induction of immunologic tolerance in man.
International archives of allergy and applied immunology    January 1, 1970   Volume 39, Issue 2-3 113-120 doi: 10.1159/000230340
Gewurz H, Moberg A, Simmons R, Pollara B, Soll R, Najarian S.No abstract available
The response of ponies to Myxovirus influenzae A-equi 2. I. Serum and nasal antibody titres following exposure. Rouse BT, Ditchfield WJ.The antibody response in serum and nasal secretions of groups of ponies vaccinated or infected with Myxovirus influenzae A-equi 2 was examined. Following infection by aerosol with live virus, a weak antibody response was recorded in both serum and secretions. Antibody levels were undetectable in secretions at 31 days after infection. After primary intramuscular vaccination with killed virus, using sodium alginate as an adjuvant, antibody was detected only in the serum. However, following revaccination, a pronounced antibody response was demonstrated in both serum and secretions. Antibody was s...
Comparative studies on the haemolytic and Treponema pallidum immobilizing complement activity in the serum of different species.
Immunology    January 1, 1970   Volume 18, Issue 1 13-18 
Müller F, Segerling M.Complement activity in the serum of eight species has been studied in two ways: by immobilization of sensitized with human or rabbit antibody and by haemolysis of sheep red cells sensitized with rabbit antibody. Serum of the pig, monkey and man was actively haemolytic but contained a heatlabile factor that immobilized unsensitized in the presence of guinea-pig complement and precluded the detection of immune immobilizing activity. Sera of other species, although without action on unsensitized treponemes, even with added guinea-pig complement, differed in their relative haemolytic and immobil...
Induction of tolerance in man to horse-IgG.
Lancet (London, England)    November 22, 1969   Volume 2, Issue 7630 1141-1142 doi: 10.1016/s0140-6736(69)90744-2
Brendel W, Land W, Hopf U, Seifert J.No abstract available
Equine influenza vaccine.
The Veterinary record    October 11, 1969   Volume 85, Issue 15 418 doi: 10.1136/vr.85.15.418
Smith SE, Best JM.No abstract available